Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4/A Registration of securities issued in business combination transactions
- 3.1 Certificate of Incorporation of the Registrant
- 3.2 Bylaws of the Registrant
- 4.1 Loan Agreement
- 4.2 First Amendment to Loan Agreement
- 4.3 Second Amendment to Loan Agreement
- 4.4 Third Amendment to Loan Agreement
- 4.5 Unlimited Guaranty
- 4.6 Unlimited Guaranty
- 4.7 Form of Subordinated Promissory Note
- 5.1 Opinion of Hallett & Perrin Regarding the Legality of Securities
- 8.1 Opinion of Hallett & Perrin Regarding Tax Matters
- 10.1 2010 Equity Compensation Plan of the Registrant
- 10.2 Partnership Interest Purchase Agreement
- 10.3 First Amendment to Partnership Interest Purchase Agreement
- 10.4 Partnership Interest Purchase Agreement and Promissory Note
- 10.5 First Amendment to Partnership Interest Purchase Agreement
- 11.1 Statement Regarding Computation of Per Share Earnings
- 21.1 Subsidiaries of the Registrant
- 23.1 Consent of Grant Thornton LLP
- 23.2 Consent of Grant Thornton LLP
- 99.1 Form of Proxy of Usmd Inc.
- 99.2 Form of Proxy of Uant Ventures, L.L.P.
- 99.3 Briefing Materials of VMG Health
USMD similar filings
Filing view
External links
Exhibit 11.1
The following table sets forth the computation of earnings per share:
Nine Months Ended September 30, | Years Ended December 31, | |||||||||||||||
2010 | 2009 | 2009 | 2008 | |||||||||||||
Basic earnings per share: | ||||||||||||||||
Net earnings attributable to USMD Inc. | $ | 11,801 | $ | 2,298 | $ | 2,303 | $ | 182 | ||||||||
Weighted-average common shares outstanding | 29,708 | 29,836 | 29,804 | 30,209 | ||||||||||||
Basic earnings per share | $ | 0.40 | $ | 0.08 | $ | 0.08 | $ | 0.01 | ||||||||
Diluted earnings per share: | ||||||||||||||||
Net earnings attributable to USMD Inc. | $ | 11,801 | $ | 2,298 | $ | 2,303 | $ | 182 | ||||||||
Weighted-average common shares outstanding | 29,708 | 29,836 | 29,804 | 30,209 | ||||||||||||
Effect of potentially dilutive securities | 533 | 17 | 73 | — | ||||||||||||
Weighted average common shares outstanding assuming dilution | 30,241 | 29,853 | 29,877 | 30,209 | ||||||||||||
Diluted earnings per share | $ | 0.39 | $ | 0.08 | $ | 0.08 | $ | 0.01 | ||||||||